Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma

Published:2015-04 Issue:4 Volume:42 Page:244-252
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Clarke Loren E.¹,Warf M.B.¹,Flake Darl D.²,Hartman Anne‐Renee¹,Tahan Steven³,Shea Christopher R.⁴,Gerami Pedram⁵,Messina Jane⁶,Florell Scott R.⁷,Wenstrup Richard J.¹,Rushton Kristen¹,Roundy Kirstin M.¹,Rock Colleen¹,Roa Benjamin¹,Kolquist Kathryn A.¹,Gutin Alexander²,Billings Steven⁸,Leachman Sancy⁹

Affiliation:

1. Myriad Genetic Laboratories, Inc. Salt Lake City UT USA

2. Myriad Genetics, Inc. Salt Lake City UT USA

3. Harvard Medical School and Beth Israel Deaconess Medical Center Boston MA USA

4. Department of Dermatology, The University of Chicago Chicago IL USA

5. Department of Pathology Northwestern Memorial Hospital Chicago IL USA

6. Department of Cutaneous Oncology Moffitt Cancer Center Tampa FL USA

7. Department of Dermatology University of Utah Salt Lake City UT USA

8. Cleveland Clinic Cleveland OH USA

9. School of Medicine, Oregon Health & Science University Portland OR USA

Funder

Myriad Genetic Laboratories, Inc.

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cup.12475

Reference27 articles.

1. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists

2. Pathology Review of Cases Presenting to a Multidisciplinary Pigmented Lesion Clinic

3. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center

4. Quality assessment by expert opinion in melanoma pathology: experience of the Pathology Panel of the Dutch Melanoma Working Party

5. Atypical spitz nevi/tumors: Lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appropriate Statistical Methods to Assess Cross-study Diagnostic 23-Gene Expression Profile Test Performance for Cutaneous Melanocytic Neoplasms;The American Journal of Dermatopathology;2024-08-14

2. Contribution of Keratinocytes in Skin Cancer Initiation and Progression;International Journal of Molecular Sciences;2024-08-13

3. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

4. Utility and Micro-Costing Framework for TERT Promoter Mutation Analysis in Melanocytic Lesions of Uncertain Malignant Potential: A Retrospective Study in Dutch Local Clinical Practice;Diagnostics;2024-08-01

5. A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management;Melanoma Management;2024-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3